Late cytomegalovirus disease following liver transplantation

This publication has 23 references indexed in Scilit:

• Allograft Rejection Predicts the Occurrence of Late‐Onset Cytomegalovirus (CMV) Disease among CMV‐Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir
  The Journal of Infectious Diseases, 2001
• Prevention of Cytomegalovirus Disease in Recipients of Solid-Organ Transplants
  Clinical Infectious Diseases, 2001
• The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation
  Nephrology Dialysis Transplantation, 2000
• Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
  New England Journal of Medicine, 1999
• Infection in solid organ transplantation
  Transplant Infectious Disease, 1999
• Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
  The Lancet, 1997
• Exposure to Cytomegalovirus from the Donated Organ Is a Risk Factor for Bacteremia in Orthotopic Liver Transplant Recipients
  Clinical Infectious Diseases, 1996
• Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
  Clinical Infectious Diseases, 1996
• OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver Transplantation
  The Journal of Infectious Diseases, 1995
• The indirect effects of cytomegalovirus infection on the outcome of organ transplantation
  Published by American Medical Association (AMA) ,1989